Phibro Animal Health Corp... (PAHC)

NASDAQ: PAHC · Real-Time Price · USD

18.65

0.04 (0.21%)

At close: May 01, 2025, 3:59 PM

18.60

-0.27%

After-hours: May 01, 2025, 04:20 PM EDT

0.21% (1D)

Bid	18.53
Market Cap	755.39M
Revenue (ttm)	1.11B
Net Income (ttm)	19.32M
EPS (ttm)	0.48
PE Ratio (ttm)	38.85
Forward PE	9.61
Analyst	Hold

Ask	18.66
Volume	112,681
Avg. Volume (20D)	272,052
Open	18.62
Previous Close	18.61
Day's Range	18.50 - 18.86
52-Week Range	16.06 - 26.55
Beta	0.63

About PAHC

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products als...

Sector Healthcare

IPO Date Apr 11, 2014

Employees 1,940

Stock Exchange NASDAQ

Ticker Symbol PAHC

Website https://www.pahc.com

Full Company Profile

Analyst Forecast

According to 4 analyst ratings, the average rating for PAHC stock is "Hold." The 12-month stock price forecast is $22, which is an increase of 17.96% from the latest price.

Stock Forecasts

Next Earnings Release

Phibro Animal Health Corporation is scheduled to release its earnings on May 7, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

+10.68%

Phibro Animal Health shares are trading higher aft... Unlock content with Pro Subscription

2 months ago

+9.88%

Phibro Animal Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance.

News

1 day ago · zacks.com

Phibro Animal Health (PAHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 days ago · zacks.com

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 week ago · businesswire.com

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro manag...

2 weeks ago · zacks.com

PAHC or BSX: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best o...

2 weeks ago · zacks.com

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 weeks ago · zacks.com

Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks

Phibro (PAHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates co...

2 weeks ago · zacks.com

Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks

The heavy selling pressure might have exhausted for Phibro (PAHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in ...